How to buy Healius shares | A$3.33

Healius Limited is a medical care facilities business based in Australia. Healius shares (HLS) are listed on the Australian Securities Exchange (ASX) and all prices are listed in Australian Dollars. Its last market close was $3.33 – the same closing value as a week prior. Healius has a trailing 12-month revenue of around $1.6 billion.

How to buy shares in Healius

1. Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
3. Search for Healius. Find the share by name or ticker symbol: HLS. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Healius reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. At today's price of $3.33, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
6. Check in on your investment. Congratulations, you own a part of Healius. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Healius's share price?

Since the stock market crash in March caused by coronavirus, Healius's share price has had significant positive movement.

Its last market close was $3.33, which is 12.01% up on its pre-crash value of $2.93 and 69.90% up on the lowest point reached during the March crash when the shares fell as low as $1.96.

If you had bought $1,000 worth of Healius shares at the start of February 2020, those shares would have been worth $770.56 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,140.43.

Healius share price

Use our graph to track the performance of HLS stocks over time.

Healius shares at a glance

• Key figures

Information last updated 2020-09-20.

Latest market close	AUDA$3.33
52-week range	AUDA$1.925 - AUDA$3.46
50-day moving average	AUDA$3.2871
200-day moving average	AUDA$2.8073
Target price	AUDA$2.76
PE ratio	28.7153
Dividend yield	AUDA$0.06 (1.81%)
Earnings per share (TTM)	AUDA$0.163

Share Trading Account Offer

IG Share Trading Offer

AUD 8

Standard brokerage - Australian shares

Share Trading Account Offer

Competitive broker fees on Australian and international shares

• Brokerage - AU shares: From AUD 5 or 0.05%
• Brokerage - US shares: USD 0
• Sign-up process: Instant
• Support - After hours: Yes

Go to site

More info

Important: Share trading carries risk of capital loss.

Compare share trading platforms

The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.

Is it a good time to buy Healius stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Healius Limited by TradingView

Healius price performance over time

Historical closes compared with the last close of A$3.33

1 week (2020-09-14)	-0.30%
1 month (2020-08-21)	1.52%
3 months (2020-06-19)	9.90%
6 months (2020-03-20)	41.10%

1 year (2019-09-20)	2.78%
2 years (2018-09-21)	15.63%
3 years (2017-09-21)	6.73%
5 years (2015-09-21)	-15.48%

Is Healius under- or over-valued?

Valuing Healius stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Healius's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Healius's P/E ratio

Healius's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 29x. In other words, Healius shares trade at around 29x recent earnings.

That's relatively low compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Healius's EBITDA

Healius's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $137.7 million (£0.0 million).

The EBITDA is a measure of a Healius's overall financial performance and is widely used to measure a its profitability.

Healius financials

Revenue TTM	$1.6 billion
Operating margin TTM	5.02%
Gross profit TTM	$518.9 million
Return on assets TTM	1.27%
Return on equity TTM	3.62%
Profit margin	-4.41%
Book value	3.101
Market capitalisation	$2.1 billion

TTM: trailing 12 months

Healius share dividends

Dividend payout ratio: 51.9% of net profits

Recently Healius has paid out, on average, around 51.9% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.81% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Healius shareholders could enjoy a 1.81% return on their shares, in the form of dividend payments. In Healius's case, that would currently equate to about A$0.06 per share.

Healius's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.

The latest dividend was paid out to all shareholders who bought their shares by 25 March 2020 (the "ex-dividend date").

Healius share price volatility

Over the last 12 months, Healius's shares have ranged in value from as little as $1.925 up to $3.46. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Healius's is 1.0723. This would suggest that Healius's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Healius overview

Healius Limited provides facilities and support services to independent general practitioners, radiologists, and other healthcare professionals in Australia. The company operates through three segments: Pathology, Imaging, and Day Hospitals. It offers diagnostic imaging services, including X-ray, ultrasound, computerized tomography, mammography, magnetic resonance imaging, nuclear medicine, positron emission tomography, and interventional radiology; and private medical laboratory and pathology services. The company also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin, cancer removal, IVF egg collection, and gynaecological surgery services. It operates 2,234 pathology sites; 15 day hospital sites; and 146 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in St Leonards, Australia.

Frequently asked questions

• What percentage of Healius is owned by insiders or institutions?

  Currently 17.213% of Healius shares are held by insiders and 34.15% by institutions.

• When does the fiscal year end for Healius?

  Healius's fiscal year ends in June.

• Where is Healius based?

  Healius's address is: 203 Pacific Highway, St Leonards, NSW, Australia, 2065

• What is Healius's ISIN number?

  Healius's international securities identification number is: AU0000033359